DK3529616T3 - In vitro- og cellebaserede assays til måling af aktiviteten af botulinum-neurotoksiner - Google Patents

In vitro- og cellebaserede assays til måling af aktiviteten af botulinum-neurotoksiner Download PDF

Info

Publication number
DK3529616T3
DK3529616T3 DK17801528.5T DK17801528T DK3529616T3 DK 3529616 T3 DK3529616 T3 DK 3529616T3 DK 17801528 T DK17801528 T DK 17801528T DK 3529616 T3 DK3529616 T3 DK 3529616T3
Authority
DK
Denmark
Prior art keywords
vitro
activity
measuring
cell
based assays
Prior art date
Application number
DK17801528.5T
Other languages
English (en)
Inventor
Min Dong
Feifan Yu
Original Assignee
Harvard College
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Harvard College filed Critical Harvard College
Application granted granted Critical
Publication of DK3529616T3 publication Critical patent/DK3529616T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004Oxidoreductases (1.)
    • C12N9/0069Oxidoreductases (1.) acting on single donors with incorporation of molecular oxygen, i.e. oxygenases (1.13)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/66Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving luciferase
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/536Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase
    • G01N33/542Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase with steric inhibition or signal modification, e.g. fluorescent quenching
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/24Hydrolases (3) acting on glycosyl compounds (3.2)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/48Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/52Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from bacteria or Archaea
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y304/00Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/24Metalloendopeptidases (3.4.24)
    • C12Y304/24069Bontoxilysin (3.4.24.69), i.e. botulinum neurotoxin
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/195Assays involving biological materials from specific organisms or of a specific nature from bacteria
    • G01N2333/33Assays involving biological materials from specific organisms or of a specific nature from bacteria from Clostridium (G)

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Toxicology (AREA)
  • Biophysics (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DK17801528.5T 2016-10-20 2017-10-19 In vitro- og cellebaserede assays til måling af aktiviteten af botulinum-neurotoksiner DK3529616T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201662410558P 2016-10-20 2016-10-20
PCT/US2017/057411 WO2018075783A2 (en) 2016-10-20 2017-10-19 In vitro and cell based assays for measuring the activity of botulinum neurotoxins

Publications (1)

Publication Number Publication Date
DK3529616T3 true DK3529616T3 (da) 2023-12-11

Family

ID=60413254

Family Applications (1)

Application Number Title Priority Date Filing Date
DK17801528.5T DK3529616T3 (da) 2016-10-20 2017-10-19 In vitro- og cellebaserede assays til måling af aktiviteten af botulinum-neurotoksiner

Country Status (19)

Country Link
US (2) US11306347B2 (da)
EP (1) EP3529616B1 (da)
JP (2) JP7227901B2 (da)
KR (1) KR102556363B1 (da)
CN (1) CN110088624B (da)
AU (1) AU2017345560A1 (da)
BR (1) BR112019007831A2 (da)
CA (1) CA3040507A1 (da)
DK (1) DK3529616T3 (da)
EA (1) EA039761B1 (da)
ES (1) ES2963830T3 (da)
FI (1) FI3529616T3 (da)
HU (1) HUE064332T2 (da)
MX (2) MX2019004431A (da)
PL (1) PL3529616T3 (da)
PT (1) PT3529616T (da)
SA (1) SA519401607B1 (da)
SG (1) SG11201903523YA (da)
WO (1) WO2018075783A2 (da)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2011348204B2 (en) 2010-12-22 2017-03-02 President And Fellows Of Harvard College Continuous directed evolution
US10920208B2 (en) 2014-10-22 2021-02-16 President And Fellows Of Harvard College Evolution of proteases
WO2016168631A1 (en) 2015-04-17 2016-10-20 President And Fellows Of Harvard College Vector-based mutagenesis system
US10392674B2 (en) 2015-07-22 2019-08-27 President And Fellows Of Harvard College Evolution of site-specific recombinases
US11524983B2 (en) 2015-07-23 2022-12-13 President And Fellows Of Harvard College Evolution of Bt toxins
WO2017019895A1 (en) 2015-07-30 2017-02-02 President And Fellows Of Harvard College Evolution of talens
UA127310C2 (uk) * 2016-05-16 2023-07-19 Презідент Енд Феллоуз Оф Гарвард Колледж Спосіб очищення і активації ботулінічного нейротоксину
DK3529616T3 (da) 2016-10-20 2023-12-11 Harvard College In vitro- og cellebaserede assays til måling af aktiviteten af botulinum-neurotoksiner
US11447809B2 (en) 2017-07-06 2022-09-20 President And Fellows Of Harvard College Evolution of tRNA synthetases
WO2019056002A1 (en) 2017-09-18 2019-03-21 President And Fellows Of Harvard College CONTINUOUS EVOLUTION FOR STABILIZED PROTEINS
US11913044B2 (en) 2018-06-14 2024-02-27 President And Fellows Of Harvard College Evolution of cytidine deaminases
WO2021011579A1 (en) * 2019-07-15 2021-01-21 President And Fellows Of Harvard College Evolved botulinum neurotoxins and uses thereof
US20210301319A1 (en) * 2020-03-26 2021-09-30 Cellex, Inc. Protease assays and their applications
CN114540419A (zh) * 2022-03-04 2022-05-27 中国人民解放军军事科学院军事医学研究院 一种分析包膜病毒膜融合效率的三功能报告系统
GB202213479D0 (en) 2022-09-14 2022-10-26 Ipsen Biopharm Ltd Cell-free clostridial neurotoxin assays
GB202404021D0 (en) 2024-03-20 2024-05-01 Ipsen Biopharm Ltd Cell-based neurotoxin assay

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4737462A (en) 1982-10-19 1988-04-12 Cetus Corporation Structural genes, plasmids and transformed cells for producing cysteine depleted muteins of interferon-β
US4518584A (en) 1983-04-15 1985-05-21 Cetus Corporation Human recombinant interleukin-2 muteins
US4950588A (en) 1985-07-10 1990-08-21 Molecular Diagnostics, Inc. Prolonged enhanced chemiluminescence
DE3537877A1 (de) 1985-10-24 1987-04-30 Geiger Reinhard Luciferin-derivate und immunoassays unter einsatz derartiger luciferin-derivate
US5004565A (en) 1986-07-17 1991-04-02 The Board Of Governors Of Wayne State University Method and compositions providing enhanced chemiluminescence from 1,2-dioxetanes
US5374534A (en) 1990-07-19 1994-12-20 Charm Sciences, Inc. Method of preparing D-luciferin derivatives
DE4210759A1 (de) 1992-04-01 1993-10-07 Boehringer Mannheim Gmbh Substituierte Thiazolin-Dioxetan-Substrate, Verfahren zur Herstellung und Verwendung
EP0760681B1 (en) 1994-05-31 1999-09-01 Allergan, Inc Modification of clostridial toxins for use as transport proteins
GB9508204D0 (en) 1995-04-21 1995-06-07 Speywood Lab Ltd A novel agent able to modify peripheral afferent function
GB9617671D0 (en) 1996-08-23 1996-10-02 Microbiological Res Authority Recombinant toxin fragments
GB9721189D0 (en) 1997-10-08 1997-12-03 Speywood Lab The Limited Analgesic conjugates
EP1064360B1 (en) 1998-03-27 2008-03-05 Prolume, Ltd. Luciferases, gfp fluorescent proteins, their nucleic acids and the use thereof in diagnostics
US6890745B1 (en) * 2000-07-19 2005-05-10 Chemicon International, Inc. Protease specific cleavable luciferases and methods of use thereof
EP1673459B1 (en) * 2003-10-10 2012-06-27 Promega Corporation Luciferase biosensor
US8753831B2 (en) 2007-06-05 2014-06-17 City Of Hope Methods for detection of botulinum neurotoxin
PL2990478T3 (pl) 2009-05-01 2017-08-31 Promega Corporation Syntetyczna lucyferaza z oplophorus o wzmocnionej emisji światła
US20140287433A1 (en) * 2011-07-19 2014-09-25 ETH Zürich Means and methods for determining clostridial neurotoxins
JP2015509372A (ja) 2012-03-07 2015-03-30 メルツ ファルマ ゲーエムベーハー ウント コンパニー カーゲーアーアー 修飾ルシフェラーゼに基づいて神経毒活性を測定するための手段および方法
WO2014060373A1 (en) * 2012-10-16 2014-04-24 Merz Pharma Gmbh & Co. Kgaa Cellular test systems for the determination of the biological activities of neurotoxin polypeptides
BR112015011255A2 (pt) * 2012-11-21 2018-09-25 Merz Pharma Gmbh & Co Kgaa polinucleotídeo que codifica um polipeptídeo de fusão, vetor, polipeptídeo de fusão, célula hospedeira, método para determinar a atividade de neurotoxina, uso do polinucleotídeo e kit.
US9797889B2 (en) * 2013-03-15 2017-10-24 Promega Corporation Activation of bioluminescence by structural complementation
CN105339790B (zh) * 2013-06-28 2018-04-17 莫茨制药有限及两合公司 用于确定神经毒素多肽在细胞中的生物活性的工具和方法
DK3274364T3 (da) * 2015-03-26 2021-10-18 Harvard College Modificeret botulinumneurotoksin
DK3529616T3 (da) 2016-10-20 2023-12-11 Harvard College In vitro- og cellebaserede assays til måling af aktiviteten af botulinum-neurotoksiner
KR20210148076A (ko) * 2018-12-11 2021-12-07 큐32 바이오 인크. 보체 연관 질환을 위한 융합 단백질 작제물

Also Published As

Publication number Publication date
US11306347B2 (en) 2022-04-19
US20220356508A1 (en) 2022-11-10
JP7227901B2 (ja) 2023-02-22
US20190276873A1 (en) 2019-09-12
EP3529616A2 (en) 2019-08-28
CN110088624B (zh) 2024-01-16
JP2019532651A (ja) 2019-11-14
MX2023004733A (es) 2023-05-10
SG11201903523YA (en) 2019-05-30
EA201990929A1 (ru) 2019-10-31
EA039761B1 (ru) 2022-03-10
JP2023011700A (ja) 2023-01-24
KR102556363B1 (ko) 2023-07-18
EP3529616B1 (en) 2023-09-06
MX2019004431A (es) 2019-08-14
CN110088624A (zh) 2019-08-02
SA519401607B1 (ar) 2022-08-04
BR112019007831A2 (pt) 2019-10-01
PT3529616T (pt) 2023-12-06
WO2018075783A3 (en) 2018-06-21
KR20190068582A (ko) 2019-06-18
AU2017345560A1 (en) 2019-05-02
FI3529616T3 (fi) 2023-12-04
PL3529616T3 (pl) 2024-03-18
HUE064332T2 (hu) 2024-03-28
US11788069B2 (en) 2023-10-17
ES2963830T3 (es) 2024-04-02
WO2018075783A2 (en) 2018-04-26
CA3040507A1 (en) 2018-04-26

Similar Documents

Publication Publication Date Title
DK3529616T3 (da) In vitro- og cellebaserede assays til måling af aktiviteten af botulinum-neurotoksiner
MA46525A (fr) Anticorps anti-lag-3 et compositions
DK3384046T3 (da) Digitalt mikrofluidisk system til enkeltcelleisolering og karakterisering af analytter
MA44659A (fr) Anticorps anti-tim-3 et compositions
DK3232404T3 (da) Fremgangsmåde og system til måling af en målgenstands dimensioner
EP3496858A4 (en) INTEGRATED MICROFLUIDIC CULTIVATION AND TESTING SYSTEM
DE112018004560A5 (de) Elektrochemische Anordnung und elektrochemisches System
CL2016001868A1 (es) Proteinas de union y sus métodos de uso
DK3380522T3 (da) Antistofmolekyler til april og anvendelser deraf
DK3255213T3 (da) Fremgangsmåde til konstruktion og fremstilling af betonkonstruktioner på grundlag af testverifikation af betontræthed
DK3402483T3 (da) Fremgangsmåder og sammensætninger til aktivering af gamma-delta-T-celler
DK2968418T3 (da) Præparater afledt af placentamaterialer til fremstilling og anvendelse deraf
DK3071963T3 (da) Kontaktfrit ægidentifikationsystem til bestemmelse af ægs levedygtighed og tilhørende fremgangsmåde
DK2917653T3 (da) Indretning og fremgangsmåde til dynamisk måling af en miljøkvalitetsfaktor.
CR20180296A (es) ANTICUERPOS ANTI-HtrA1 Y MÉTODOS DE USO
CL2016001921A1 (es) Proteínas inmovilizadas y uso de las mismas
DK3320099T3 (da) Membranforankret eller udskilt antistof til ekspression af lentivirale vektorer
FR3036939B1 (fr) Autocuiseur pourvu d'une soupape demontable et d'un capteur de temperature
DK3433360T3 (da) Proteaser med forbedret enzymstabilitet i vaskemidler
DK3541961T3 (da) Streptococcus thermophilus til anvendelse i fremstilling af fermenterede produkter
CL2018003424A1 (es) Detección in situ de microorganismos
DK3143403T3 (da) Fremgangsmåder til påvisning og/eller måling af anti-lægemiddelantistoffer, især behandlingsinducerede anti-lægemiddelantistoffer
HK1208706A1 (en) Cellular test systems for the determination of the biological activities of neurotoxin polypeptides
DK3207374T3 (da) Fremgangsmåde og system til bestemmelse af koncentrationen af en analyt i en fluidprøve
DK3577237T3 (da) Fremgangsmåde til indikation af en tilstedeværelse eller ikke-tilstedeværelse af prostatacancer hos individer med bestemte karakteristika